Drug recall · July 13, 2016
XCEL Capsules recall
Why: Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared fluoxetine, an FDA approved drug used to treat depression, anxiety, panic attacks, obsessive-compulsive disorder, or bulimia and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
XCEL Capsules, 300 mg, 60-count bottles, Manufactured for JNS Health
- Lots / codes
All lots
- Quantity
- N/A
- Company
- Bee Extremely Amazed LLC, Jewett, OH
- Distribution
- Nationwide
- Initiated
- December 15, 2015 · Voluntary: Firm initiated
- Classified
- July 6, 2016
- Reported
- July 13, 2016
- Ended
- April 23, 2020
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.